Literature DB >> 17462479

Prevalence of interstitial cystitis in a primary care setting.

Matt T Rosenberg1, Shari Page, Matthew A Hazzard.   

Abstract

In this article, we report a study that assessed the prevalence of interstitial cystitis (IC) in a primary care office using symptom-based and improved diagnosis-based assessment modalities. Over the course of 1 year, all patients > or = 18 years of age who presented for a primary care office visit were administered the Pelvic Pain and Urgency/Frequency (PUF) questionnaire. Patients with potential IC as indicated by PUF score were selected for further interview and, when appropriate, a Potassium Sensitivity Test (PST) or Anesthetic Bladder Challenge (ABC). Those given the PST were queried afterward regarding the tolerability of the test. Of 3883 patients initially surveyed, 13.1% (n +/- 509) reported PUF scores suggestive of probable IC, including 17.5% (357 of 2043) of women and 8.3% (152 of 1840) of men. Overall, 4.3% (168 of 3883) of patients in this primary care population was diagnosed with IC on the basis of history, PUF score, patient interview, and results of the PST or ABC. The PST was found to be comparable to, and in most cases less painful than, several standard office-based procedures. IC is a prevalent disease in the general primary care population. The PUF questionnaire represents an easy-to-use approach for IC symptom screening, and the PST and the ABC are useful and relatively noninvasive adjuncts in the diagnosis of IC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462479     DOI: 10.1016/j.urology.2006.03.085

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  14 in total

Review 1.  Pelvic pain in urogynaecology. Part I: evaluation, definitions and diagnoses.

Authors:  Tilemachos Kavvadias; Kaven Baessler; Bernhard Schuessler
Journal:  Int Urogynecol J       Date:  2010-07-20       Impact factor: 2.894

Review 2.  Sacral neuromodulation stimulation for IC/PBS, chronic pelvic pain, and sexual dysfunction.

Authors:  Jennifer Yonaitis Fariello; K Whitmore
Journal:  Int Urogynecol J       Date:  2010-12       Impact factor: 2.894

3.  Hunner's lesions.

Authors:  Joel M H Teichman
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

4.  Prevalence of painful bladder syndrome/interstitial cystitis-like symptoms in women: a population-based study in Korea.

Authors:  Jin Ho Choe; Hwancheol Son; Yun Seob Song; Joon Chul Kim; Jeong Zoo Lee; Kyu-Sung Lee
Journal:  World J Urol       Date:  2010-03-26       Impact factor: 4.226

Review 5.  [Interstitial cystitis : Diagnosis and pharmacological and surgical therapy].

Authors:  A Gonsior; J Neuhaus; L C Horn; T Bschleipfer; J-U Stolzenburg
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

Review 6.  Minimally invasive therapies for chronic pelvic pain syndrome.

Authors:  Salim A Wehbe; Jennifer Y Fariello; Kristene Whitmore
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

7.  The genetic and environmental contribution to the occurrence of bladder pain syndrome: an empirical approach in a nationwide population sample.

Authors:  Daniel Altman; Cecilia Lundholm; Ian Milsom; Ralph Peeker; Magnus Fall; Anastasia N Iliadou; Nancy L Pedersen
Journal:  Eur Urol       Date:  2010-11-05       Impact factor: 20.096

8.  Association of bladder pain syndrome/interstitial cystitis with urinary calculus: a nationwide population-based study.

Authors:  Joseph Keller; Yi-Kuang Chen; Herng-Ching Lin
Journal:  Int Urogynecol J       Date:  2012-08-16       Impact factor: 2.894

9.  Management strategies for painful bladder syndrome.

Authors:  Trevin C Lau; Joan M Bengtson
Journal:  Rev Obstet Gynecol       Date:  2010

10.  A survey of primary care physician practices in the diagnosis and management of women with interstitial cystitis/painful bladder syndrome.

Authors:  J Quentin Clemens; Elizabeth A Calhoun; Mark S Litwin; Elizabeth Walker-Corkery; Talar Markossian; John W Kusek; Mary McNaughton-Collins
Journal:  Urology       Date:  2010-03-19       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.